Overview Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates Status: RECRUITING Trial end date: 2025-11-01 Target enrollment: Participant gender: Summary This study is an open-label drug-drug interaction (DDI) study of ZYN002 transdermal gel and multiple drugs.Phase: PHASE1 Details Lead Sponsor: Harmony Biosciences Management, Inc.